ArticleInternational journal of nanomedicine2025

Carrier-Free Silibinin/Sorafenib Microparticles Alleviate Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating Fatty Acid Metabolism.

Feifei Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.